NADAC acquisition cost data for AMETHIA 0.15-0.03-0.01 MG TAB. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 51862004701 | $0.3223 | 2022-12-21 | Rx |
| 51862004791 | $0.3223 | 2022-12-21 | Rx |
| 51862004701 | $0.3223 | 2022-12-21 | Rx |
| 51862004791 | $0.3223 | 2022-12-21 | Rx |
Generic: L-Norgest/E.Estradiol-E.Estrad | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $60.8K | 440 | 208 | $1.54 |
| 2020 | $58.3K | 433 | 238 | $1.49 |
| 2021 | $36.0K | 344 | 172 | $1.14 |
| 2022 | $16.3K | 180 | 94 | $0.9743 |
| 2023 | $2.0K | 21 | 18 | $1.03 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.